Your browser doesn't support javascript.
loading
Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents.
Kesicki, Edward A; Bailey, Mai A; Ovechkina, Yulia; Early, Julie V; Alling, Torey; Bowman, Julie; Zuniga, Edison S; Dalai, Suryakanta; Kumar, Naresh; Masquelin, Thierry; Hipskind, Philip A; Odingo, Joshua O; Parish, Tanya.
Afiliação
  • Kesicki EA; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Bailey MA; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Ovechkina Y; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Early JV; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Alling T; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Bowman J; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Zuniga ES; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Dalai S; Jubilant Chemsys Limited, B-34, Sector 58, Noida, India.
  • Kumar N; Jubilant Chemsys Limited, B-34, Sector 58, Noida, India.
  • Masquelin T; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Hipskind PA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, United States of America.
  • Odingo JO; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
  • Parish T; TB Discovery Research, Infectious Disease Research Institute, Seattle, Washington, United States of America.
PLoS One ; 11(5): e0155209, 2016.
Article em En | MEDLINE | ID: mdl-27171280
ABSTRACT
The 2-aminothiazole series has anti-bacterial activity against the important global pathogen Mycobacterium tuberculosis. We explored the nature of the activity by designing and synthesizing a large number of analogs and testing these for activity against M. tuberculosis, as well as eukaryotic cells. We determined that the C-2 position of the thiazole can accommodate a range of lipophilic substitutions, while both the C-4 position and the thiazole core are sensitive to change. The series has good activity against M. tuberculosis growth with sub-micromolar minimum inhibitory concentrations being achieved. A representative analog was selective for mycobacterial species over other bacteria and was rapidly bactericidal against replicating M. tuberculosis. The mode of action does not appear to involve iron chelation. We conclude that this series has potential for further development as novel anti-tubercular agents.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiazóis / Antituberculosos Limite: Animals Idioma: En Revista: PLoS One Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiazóis / Antituberculosos Limite: Animals Idioma: En Revista: PLoS One Ano de publicação: 2016 Tipo de documento: Article